Cargando…
SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610239/ https://www.ncbi.nlm.nih.gov/pubmed/34826382 http://dx.doi.org/10.1016/S1473-3099(21)00697-6 |
_version_ | 1784603069294575616 |
---|---|
author | Thiruvengadam, Ramachandran Binayke, Akshay Awasthi, Amit |
author_facet | Thiruvengadam, Ramachandran Binayke, Akshay Awasthi, Amit |
author_sort | Thiruvengadam, Ramachandran |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8610239 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86102392021-11-24 SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines Thiruvengadam, Ramachandran Binayke, Akshay Awasthi, Amit Lancet Infect Dis Comment Elsevier Ltd. 2022-03 2021-11-23 /pmc/articles/PMC8610239/ /pubmed/34826382 http://dx.doi.org/10.1016/S1473-3099(21)00697-6 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Comment Thiruvengadam, Ramachandran Binayke, Akshay Awasthi, Amit SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines |
title | SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines |
title_full | SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines |
title_fullStr | SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines |
title_full_unstemmed | SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines |
title_short | SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines |
title_sort | sars-cov-2 delta variant: a persistent threat to the effectiveness of vaccines |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610239/ https://www.ncbi.nlm.nih.gov/pubmed/34826382 http://dx.doi.org/10.1016/S1473-3099(21)00697-6 |
work_keys_str_mv | AT thiruvengadamramachandran sarscov2deltavariantapersistentthreattotheeffectivenessofvaccines AT binaykeakshay sarscov2deltavariantapersistentthreattotheeffectivenessofvaccines AT awasthiamit sarscov2deltavariantapersistentthreattotheeffectivenessofvaccines |